- Prof. Jan B. Vermorken
- Department of Medical Oncology, Antwerp University Hospital, Edegem, Belgium.
Website | E-mail
- Dr. Petr Szturz
Medical Oncology, Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Lausanne, Switzerland.
Website | E-mail
Special Issue Introduction
"Head and neck cancer" is the term used to describe a number of different malignant tumors that develop in or around the throat, larynx, nose, sinuses, and mouth. Head and Neck cancer is among the most common cancers worldwide, with a high prevalence in south East Asia, Brazil and central Europe. At present, head and neck cancers, remain a challenging disease to treat successfully. Existing screening options are primarily limited to clinical exams and radiological tests, which are imprecise and may result in delayed detection. Subsequently, many head and neck cancer patients thus present with advanced stage disease, leading to poorer outcomes. As a result, little progress has been made in improving survival from head and neck cancer.
The goal of this special issue is to delve deeper into the biology of head and neck cancer, uncover innovative therapeutic approaches, and identify new avenues for tackling this clinically challenging cancer.
We will welcome submissions on the following topics, but are not confined to:
● Molecular Mechanisms of Head and Neck Cancer;
● Imaging in Head and Neck Cancers;
● Clinical Diagnosis and Assessment of Head and Neck Cancers;
● Radiation Therapy in Head and Neck Cancers;
● Head and Neck Cancer Surgery;
● Immunotherapy for Head and Neck Cancers;
● Other Emerging Treatment Strategies for Head and Neck Cancers
Head and neck cancer, diagnosis, immunotherapy, emerging treatment strategies
Submission Deadline30 May 2022